Company / R&D per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.32
FY2025
5-year range
$0.32 / $0.86
FY2021-FY2025
Trend
-30.7%
vs FY2024
Sector context
#93 of 108
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s r&d per share of $0.32 is lower than 86% of companies in the Health Care sector (FY2025). R&D per Share has declined for 3 consecutive years, from $0.86 in FY2022 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of -2.4%.
Declined from $0.74 to $0.32 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -27.7%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 108This company $0.32 Sector average $2.07
▼
-84.4% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 30.7% year-over-year.
- Ranks #93 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | -30.7% |
| FY2024 | $0.47 | -36.6% |
| FY2023 | $0.74 | -14.1% |
| FY2022 | $0.86 | +55.4% |
| FY2021 | $0.55 | +50.8% |
| FY2020 | $0.37 | -6.2% |
| FY2019 | $0.39 | -27.4% |
| FY2018 | $0.54 | -23.6% |
| FY2017 | $0.70 | -16.6% |
| FY2016 | $0.85 | +38.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026